In vivo biodistribution and accumulation of 89Zr in mice

被引:236
作者
Abou, Diane S. [1 ]
Ku, Thomas [1 ]
Smith-Jones, Peter M. [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Radiochem Serv, Dept Radiol, New York, NY 10065 USA
[2] Univ Colorado Denver, Dept Radiol, Aurora, CO 80045 USA
关键词
PET; Zr-89; Chloride; Oxalate; Phosphate; Bone seeker; MONOCLONAL-ANTIBODIES; MEMBRANE ANTIGEN; ZIRCONIUM; ZR-89-TRASTUZUMAB; EXPRESSION; IMMUNOPET; LEAD;
D O I
10.1016/j.nucmedbio.2010.12.011
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: The present investigation focuses on the chemical and biological fate of Zr-89 in mice. Electrophoreses of Zr-89 solvated or chelated in different conditions are here presented. The biological fate of mice injected with [Zr-89]Zr-oxalate, [Zr-89]Zr-chloride, [Zr-89]Zr-phosphate, [Zr-89]Zr-desferrioxamine and [Zr-89]Zr-citrate is studied with the biodistribution, the clearances and positron emission tomography images. A special focus is also given regarding the quality of Zr-89 bone accumulation. Methods: Electrophoreses were carried out on chromatography paper and read by gamma counting. Then, the solutions were intravenously injected in mice, imaged at different time points and sacrificed. The bones, the epiphysis and the marrow substance were separated and evaluated with gamma counts. Results: The clearances of [Zr-89]Zr-chloride and [Zr-89]Zr-oxalate reached 20% of injected dose (ID) after 6 days whereas [Zr-89]Zr-phosphate was only 5% of ID. [Zr-89-]Zr-citrate and [Zr-89]Zr-DFO were noticeably excreted after the first day postinjection (p.i.). [Zr-89]Zr-chloride and [Zr-89]Zr-oxalate resulted in a respective bone uptake of similar to 15% ID/g and similar to 20% ID/g at 8 h p.i. with minor losses after 6 days. [Zr-89]Zr-citrate bone uptake was also observed, but [Zr-89]Zr-phosphate was absorbed in high amounts in the liver and the spleen. The marrow cells were insignificantly radioactive in comparison to the calcified tissues. Conclusion: Despite the complexity of Zr coordination, the electrophoretic analyses provided detailed evidences of Zr charges either as salts or as complexes. This study also shows that weakly chelated, Zr-89 is a bone seeker and has a strong affinity for phosphate. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 29 条
[1]   DISTRIBUTION OF ZIRCONIUM AND NIOBIUM IN MICE [J].
BACKSTROM, J ;
HAMMARSTROM, L ;
NELSON, A .
ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1967, 6 (02) :122-+
[2]  
CHISHOLM H, 1911, ENCY BRITANNICA DICT, P990
[3]   Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer [J].
Dijkers, E. C. ;
Munnink, T. H. Oude ;
Kosterink, J. G. ;
Brouwers, A. H. ;
Jager, P. L. ;
de Jong, J. R. ;
van Dongen, G. A. ;
Schroder, C. P. ;
Lub-de Hooge, M. N. ;
de Vries, E. G. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) :586-592
[4]   Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging [J].
Dijkers, Eli C. F. ;
Kosterink, Jos G. W. ;
Rademaker, Anna P. ;
Perk, Lars R. ;
van Dongen, Guus A. M. S. ;
Bart, Joost ;
de Jong, Johan R. ;
de Vries, Elisabeth G. E. ;
Lub-de Hooge, Marjolijn N. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) :974-981
[5]   Predictive factors of oxaliplatin neurotoxicity: The involvement of the oxalate outcome pathway [J].
Gamelin, Laurence ;
Capitain, Olivier ;
Morel, Alain ;
Dumont, Agnes ;
Traore, Sory ;
Anne, Le Bouil ;
Gilles, Simard ;
Boisdron -Celle, Michele ;
Gamelin, Erick .
CLINICAL CANCER RESEARCH, 2007, 13 (21) :6359-6368
[6]   ZIRCONIUM - AN ABNORMAL TRACE-ELEMENT IN BIOLOGY [J].
GHOSH, S ;
SHARMA, A ;
TALUKDER, G .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1992, 35 (03) :247-271
[7]   89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo [J].
Holland, Jason P. ;
Divilov, Vadim ;
Bander, Neil H. ;
Smith-Jones, Peter M. ;
Larson, Steven M. ;
Lewis, Jason S. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (08) :1293-1300
[8]   Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab [J].
Holland, Jason P. ;
Caldas-Lopes, Eloisi ;
Divilov, Vadim ;
Longo, Valerie A. ;
Taldone, Tony ;
Zatorska, Danuta ;
Chiosis, Gabriela ;
Lewis, Jason S. .
PLOS ONE, 2010, 5 (01)
[9]   Standardized methods for the production of high specific-activity zirconium-89 [J].
Holland, Jason P. ;
Sheh, Yiauchung ;
Lewis, Jason S. .
NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (07) :729-739
[10]  
*IFLA, 1996, GUID CAR US LAB AN